Deciphering the Therapeutic Potential of Novel Pentyloxyamide-Based Class I, IIb HDAC Inhibitors against Therapy-Resistant Leukemia.
Fischer F, Schliehe-Diecks J, Tu JW, Gangnus T, Ho YL, Hebeis M, Alves Avelar LA, Scharov K, Watrin T, Kemkes M, Stachura P, Daugs K, Biermann L, Kremeyer J, Horstick N, Span I, Pandyra AA, Borkhardt A, Gohlke H, Kassack MU, Burckhardt BB, Bhatia S, Kurz T.
Fischer F, et al. Among authors: ho yl.
J Med Chem. 2024 Dec 12;67(23):21223-21250. doi: 10.1021/acs.jmedchem.4c02024. Epub 2024 Nov 27.
J Med Chem. 2024.
PMID: 39602240